Key facts
- This page summarizes Phillip G. Febbo's Form 4 filing for ILLUMINA, INC. (ILMN).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2023, 10:14.
Phillip G. Febbo - 01 Mar 2023 Form 4 Insider Report for ILLUMINA, INC. (ILMN)
- Reporting relationship
- SVP Chief Medical Officer
- Issuer ticker
- ILMN
- Reported as of
- 01 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2023, 10:14:34 UTC
- Prior SEC filing
- 23 Feb 2023
- Next SEC filing
- 04 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Maynes for Phillip Febbo
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Phillip G. Febbo filed Form 4 for ILLUMINA, INC. (ILMN) on 03 Mar 2023.
Change
- Previous filing in this sequence was filed on 23 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ILMN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +7,556
- Change %
- +105%
- Price
- $0.000000
- Shares after
- 14,786
- Date
- 01 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ILMN
transaction
Derivative
Performance Shares
Award
- Transaction value
- $0
- Shares
- +3,023
- Change %
- Price
- $0.000000
- Shares after
- 3,023
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,023
- Exercise price
- Footnotes
- F2
ILMN
transaction
Derivative
Performance Shares
Award
- Transaction value
- $0
- Shares
- +4,534
- Change %
- Price
- $0.000000
- Shares after
- 4,534
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,534
- Exercise price
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.
Footnote F2
Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.
Footnote F3
Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.